OTC Markets Group uses cookies and similar technologies to help us understand how you use our websites, as further disclosed in our Privacy Policy. Our Terms of Service contain important information including restrictions on your use of our websites. By clicking “Accept”, or by continuing to use our websites, you consent to the use of cookies and agree to the terms of the OTC Markets Group Privacy Policy and Terms of Service.
RSCI
Redwood Scientific Technologies, Inc.
Common Stock
Warning! Limited Information
OTC Markets Group has confirmed that this company has limited disclosure or financial information publicly available, but meets a minimum requirement for public quoting under Rule 15c2-11. The Pink Limited Information tier may include companies that are delinquent in their filing obligations with the SEC, a foreign exchange or regulator, or under the Pink Disclosure Guidelines, as well as non-U.S. companies listed on a foreign exchange that does not require English disclosure and do not certify their compliance with SEC Rule 12g3-2(b).N/A
N/A
N/A
N/A
Real-Time Level 2 Quote
Bid
Ask
MPID MPID | Bid Price Bid Price | Size Size | Time Time |
|---|---|---|---|
ETRF | 24.90 | >year | |
CDEL | 21.92 | 03/16 | |
MACM | 18.95 | >year | |
NITE | 18.95 | >year | |
CSTI | 18.55 | >year |
MPID MPID | Ask Price Ask Price | Size Size | Time Time |
|---|---|---|---|
INTL | 19.40 | >year | |
NITE | 19.40 | >year | |
MACM | 19.43 | >year | |
MAXM | 20.11 | >year | |
CANT | 22.05 | >year |
Unlock Real-Time quotes For RSCIFind Out More
Trade Data
News
Filings and Disclosure
Company Description
Redwood Scientific Technologies (RSCI) is a pharmaceutical company that develops,
operates, and markets innovative over-the-counter products in a sublingual oral thin film
strip. RSCI has begun clinical trials on two new products that will be marketed to help
stop the addiction to nicotine. Redwood will bring back its product TBX-FREE for the
addiction to nicotine in cigarettes. Redwood will also begin a trial on a product to stop
the addiction to nicotine in vape delivery. Redwood Scientific is targeting the clinical trials
that will conclude in 2024.
Videos
Companies that may have limited disclosure or financial information publicly available, but meet a minimum requirement for public quoting under Rule 15c2-11.
Pink Limited Information
The company’s transfer agent has verified its outstanding shares directly to OTC Markets.
The Shell Risk designation indicates that a company displays characteristics common to Shell Companies.
Subscribe to Our Newsletter
Stay up to date on the latest company news, industry trends and regulatory changes that affect our markets and learn about members of our community.
